Membrane technology

Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients

Retrieved on: 
Friday, September 20, 2019
Medicine, Isoquinolines, Roxadustat, Clinical medicine, Membrane technology, Dose, Chemistry, Dialysis

The dosage thereafter should be adjusted according to the patients condition; however, the maximum dose should not exceed 3.0mg/kg.

Key Points: 
  • The dosage thereafter should be adjusted according to the patients condition; however, the maximum dose should not exceed 3.0mg/kg.
  • For adults, the usual dosage is 70 or 100mg, the starting dose, as roxadustat orally administered three times weekly.
  • The dosage thereafter should be adjusted according to the patients condition; however, the maximum dose should not exceed 3.0mg/kg.
  • In addition to receiving approval from the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, roxadustat is approved in China for treatment of anemia associated with CKD in both dialysis-dependent and non-dialysis-dependent CKD patients.

Celgard Files Lawsuit Against Senior for Patent Infringement of Ceramic Coated Separators Used in Lithium Batteries

Retrieved on: 
Thursday, September 19, 2019
Chemistry, Physical sciences, Natural sciences, Battery, Membrane technology, Polymers, Separator, Lithium-ion battery, Lithium

Specifically, Celgard is pursuing claims against Senior for selling infringing ceramic coated and polypropylene separators made by Senior in Shenzhen, China, and for misappropriating Celgard's trade secrets and confidential information.

Key Points: 
  • Specifically, Celgard is pursuing claims against Senior for selling infringing ceramic coated and polypropylene separators made by Senior in Shenzhen, China, and for misappropriating Celgard's trade secrets and confidential information.
  • The complaint alleges that Senior has infringed Celgard's U.S. Patent RE47,520 (formerly U.S. Patent 6,432,586) and U.S. Patent 6,692,867.
  • The '520 Patent covers innovative ceramic coated separators first developed by Celgard for high-energy rechargeable lithium-ion batteries.
  • Celgard specializes in coated and uncoated dry-process microporous membranes used as separators that are a major component of lithium-ion batteries.

Celgard Files Lawsuit Against Senior for Patent Infringement of Ceramic Coated Separators Used in Lithium Batteries

Retrieved on: 
Thursday, September 19, 2019
Chemistry, Physical sciences, Natural sciences, Battery, Membrane technology, Polymers, Separator, Lithium-ion battery, Lithium

Specifically, Celgard is pursuing claims against Senior for selling infringing ceramic coated and polypropylene separators made by Senior in Shenzhen, China, and for misappropriating Celgard's trade secrets and confidential information.

Key Points: 
  • Specifically, Celgard is pursuing claims against Senior for selling infringing ceramic coated and polypropylene separators made by Senior in Shenzhen, China, and for misappropriating Celgard's trade secrets and confidential information.
  • The complaint alleges that Senior has infringed Celgard's U.S. Patent RE47,520 (formerly U.S. Patent 6,432,586) and U.S. Patent 6,692,867.
  • The '520 Patent covers innovative ceramic coated separators first developed by Celgard for high-energy rechargeable lithium-ion batteries.
  • Celgard specializes in coated and uncoated dry-process microporous membranes used as separators that are a major component of lithium-ion batteries.

Global Fuel Cell Technology Market Overview & Outlook 2017-2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 19, 2019
Alternative energy, Energy, Energy, Companies, Articles, Hydrogen technologies, Hydrogen economy, Alternative energy, Electrolysis, Hydrogenics, Membrane technology, Fuel cell, FuelCell Energy, Kyocera

The "Fuel Cell Technology - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Fuel Cell Technology - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Fuel Cell Technology Market is expected to grow at a CAGR of 16.2% during the forecast period.
  • However, factors such as high catalyst cost and lack of proper fuel infrastructures are hampering the market growth.
  • Some of the key players in Fuel Cell Technology market include AFC energy (UK), Ballard Power Systems Inc., Ceramic Fuel Cell, Doosan Corporation, FuelCell Energy, Hydrogenics, Kyocera (Japan), Panasonic Corporation, Plug Power and Toshiba Corporation.

Fresenius Medical Care Launches 4008A™ Dialysis Machine in China

Retrieved on: 
Thursday, September 19, 2019
Medical devices, Health, Hospitals, Other Health, Membrane technology, Natural sciences, Medicine, Clinical medicine, Fresenius Medical Care, Fresenius, Dialysis, Hemodialysis

Fresenius Medical Care, the worlds leading provider of dialysis products and services, today announced the launch of its 4008ATM dialysis machine in China.

Key Points: 
  • Fresenius Medical Care, the worlds leading provider of dialysis products and services, today announced the launch of its 4008ATM dialysis machine in China.
  • View the full release here: https://www.businesswire.com/news/home/20190919005325/en/
    Fresenius Medical Care proudly launched the 4008A dialysis machine in China today.
  • It is important to enhance the accessibility and affordability of dialysis in primary care, especially in the rural regions in China, Mr. Alan Chen, Executive Vice President of Fresenius Medical Care, Greater China said.
  • Through its network of 3,996 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 339,550 patients around the globe.

The Global Nanofiltration Membrane Market size is expected to reach $845.2 Million by 2025, rising at a market growth of 5.3% CAGR during the forecast period

Retrieved on: 
Wednesday, September 18, 2019
Membrane technology, Chemistry, Water treatment, Physical sciences, Natural sciences, Water technology, Filters, Water desalination, Nanofiltration, Urbanization, Membrane, Economic growth

The Global Nanofiltration Membrane Market size is expected to reach $845.2 Million by 2025, rising at a market growth of 5.3% CAGR during the forecast period.

Key Points: 
  • The Global Nanofiltration Membrane Market size is expected to reach $845.2 Million by 2025, rising at a market growth of 5.3% CAGR during the forecast period.
  • Accelerated urbanization and industrialization across developing economies like India and China and increased demand for domestic and industrial water are expected to enhance the growth of the nanofiltration membrane market.
  • High installation expenses and absence of resources in emerging economies such as India, however, limit the market growth.
  • Based on Application, the market is segmented into Water & Wastewater Treatment, Food and Beverages, Chemical & Petrochemicals, Pharmaceutical & Biomedical and Others.

Entegris Acquires Hangzhou Anow Microfiltration Co., Ltd.

Retrieved on: 
Wednesday, September 18, 2019
Engineering, Semiconductor, Chemicals, Plastics, Technology, Manufacturing, Chemistry, Natural sciences, Physical sciences, Membrane technology, Water technology, Entegris, Water treatment, Microfiltration, Membrane, Fine chemical, Filtration, Hangzhou

Entegris, Inc. ( Nasdaq: ENTG ), a leader in specialty chemicals and advanced materials solutions, announced today it has acquired Hangzhou Anow Microfiltration Co., Ltd., a filtration company for diverse industries including semiconductor, pharmaceutical, and medical.

Key Points: 
  • Entegris, Inc. ( Nasdaq: ENTG ), a leader in specialty chemicals and advanced materials solutions, announced today it has acquired Hangzhou Anow Microfiltration Co., Ltd., a filtration company for diverse industries including semiconductor, pharmaceutical, and medical.
  • Headquartered in the Xindeng New District, Fuyang National Economic and Technological Development Zone, Hangzhou, Anow is now part of the Microcontamination Control Division of Entegris.
  • The addition of Anow not only brings new polymeric membrane technologies and liquid filtration offerings to Entegris global portfolio, but also provides Entegris with additional infrastructure to manufacture filtration products in the Asia region.
  • Entegris has acquired Anow for approximately $73 million in cash, subject to certain post-closing adjustments, and excludes cash contributed to fund near term capital expenditures.

Intermountain Healthcare’s New Patient-Centered Kidney Care Program Focuses on At-Home Kidney Dialysis, Pre-emptive Transplant

Retrieved on: 
Wednesday, September 11, 2019
Insurance, Managed care, General Health, Health, Hospitals, Professional services, Medicine, Clinical medicine, Medical specialties, Membrane technology, Renal dialysis, Nephrology, Intermountain Healthcare, Intermountain Medical Center, Kidney transplantation, Dialysis, Telehealth, Home hemodialysis

But now, Intermountain Healthcare in Salt Lake City is launching a unique Kidney Care Center that brings doctors, nurses, dietitians and together to help kidney patients get the vital care they need in a convenient and easy manner even at home.

Key Points: 
  • But now, Intermountain Healthcare in Salt Lake City is launching a unique Kidney Care Center that brings doctors, nurses, dietitians and together to help kidney patients get the vital care they need in a convenient and easy manner even at home.
  • The new first of-its-kind Kidney Care Center and service is located at Intermountain Medical Center but will serve patients wherever they live through telehealth care and at-home dialysis.
  • If kidney disease gets worse, wastes can build to high levels in the blood and make patients feel sick.
  • The goal of the new kidney care center is to increase access to treatment, specifically before dialysis is ever needed.

Global $118 Bn Dialysis (Hemodialysis, Peritoneal Dialysis) Market to 2025: Top Players are Baxter Intl, Fresenius Medical Care, DaVita, Asahi Kasei Corp and Medtronic

Retrieved on: 
Tuesday, September 10, 2019
Medicine, Companies, Health, Membrane technology, Detoxification, Dialysis, DaVita Inc., Fresenius Medical Care, Fresenius, Baxter International, Medtronic, Renal dialysis

Global Dialysis Market is expected to be more than US$ 118 Billion by 2025.

Key Points: 
  • Global Dialysis Market is expected to be more than US$ 118 Billion by 2025.
  • Globally dialysis market is increasing due to growth in the number of end-stage renal disease patient numbers.
  • The service segment is a clear winner in the global dialysis market.
  • Baxter International Inc, Fresenius Medical Care, DaVita Inc., Asahi Kasei Corporation and Medtronic Plc, are some of the top companies operating in the global dialysis market; which has been studied thoroughly in the report.

Fresenius Medical Care North America Achieves Record Growth in Home Dialysis

Retrieved on: 
Tuesday, September 10, 2019
Medicine, Clinical medicine, Health, Renal dialysis, Fresenius, Societates Europaeae, Membrane technology, Home hemodialysis, NxStage, Dialysis, Draft:Rice Powell, Rockwell Medical

WALTHAM, Mass., Sept. 10, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, announces record growth in home dialysis in the six months since its merger with NxStage Medical Inc.

Key Points: 
  • WALTHAM, Mass., Sept. 10, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, announces record growth in home dialysis in the six months since its merger with NxStage Medical Inc.
  • In 2019 alone, Fresenius Medical Care North America has achieved these additional home dialysis initiatives and milestones:
    Educated 30,000 patients with CKD or ESRD about home dialysis with the help of 180 Kidney Care Advocates.
  • The company continues to offer meaningful, educational information to the public through its Fresenius Kidney Care patient-facing website and its Fresenius Medical Care North America website and newsroom .
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.